Cargando…
PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway
Osteosarcoma (OS) is the most common primary malignant bone tumor mainly occurring in children and adolescents. In past decades, studies revealed that PARK2 was a vital tumor suppressor gene in many malignant solid tumors. However, the role of PARK2 in OS remains largely unclear. Therefore, we asses...
Autores principales: | Lei, Zhong, Duan, Huijie, Zhao, Tengfei, Zhang, Yuxiang, Li, Guoqi, Meng, Jiahong, Zhang, Suzhan, Yan, Weiqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841444/ https://www.ncbi.nlm.nih.gov/pubmed/29515107 http://dx.doi.org/10.1038/s41419-018-0401-8 |
Ejemplares similares
-
Water Extract of Sporoderm-Broken Spores of Ganoderma lucidum Induces Osteosarcoma Apoptosis and Restricts Autophagic Flux
por: Zhang, Wenkan, et al.
Publicado: (2019) -
PARK2 Suppresses Proliferation and Tumorigenicity in Non-small Cell Lung Cancer
por: Duan, Huijie, et al.
Publicado: (2019) -
Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma
por: Cheng, Jin-Zhang, et al.
Publicado: (2018) -
Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway
por: Jia, Fei, et al.
Publicado: (2022) -
FANCD2 inhibits ferroptosis by regulating the JAK2/STAT3 pathway in osteosarcoma
por: Li, Xujun, et al.
Publicado: (2023)